Sekar Kathiresan - Director at Maze Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
MAZE on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sekar Kathiresan since 01 Feb 2025

Holdings reported by Sekar Kathiresan for Maze Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 103,723 30 Jan 2025 Direct
Stock Option (Right to Buy) 18,000 22 Sep 2025 Direct Common Stock

Transactions reported by Sekar Kathiresan for Maze Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.